RECURSION PHARMACEUTICALS IN shareholders Q3 2023

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 193 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.

RECURSION PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Russell Investments Group, Ltd. 130,901$1,001,3900.00%
Mirae Asset Global Investments Co., Ltd. 106,354$813,6070.00%
Cambridge Investment Research Advisors, Inc. 59,839$4580.00%
Arizona State Retirement System 36,801$281,5280.00%
Hudson Bay Capital Management LP 80,000$612,0000.00%
DIMENSIONAL FUND ADVISORS LP 845,164$6,465,7040.00%
STRS OHIO 46,000$3510.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 144,330$1,104,1250.00%
Skandinaviska Enskilda Banken AB (publ) 15,500$1190.00%
Leucadia National 10,000$76,5000.00%
QRG CAPITAL MANAGEMENT, INC. 11,295$86,4070.00%
VOYA INVESTMENT MANAGEMENT LLC 82,296$629,5650.00%
Private Advisor Group, LLC 10,326$78,9960.00%
BANK OF AMERICA CORP /DE/ 898,760$6,875,5140.00%
WELLS FARGO & COMPANY/MN 244,884$1,873,3630.00%
AMERICAN CENTURY COMPANIES INC 85,925$657,3260.00%
UBS Group AG 342,679$2,621,4940.00%
NEW YORK STATE COMMON RETIREMENT FUND 48,237$3690.00%
Wealthspire Advisors, LLC 11,327$86,6520.00%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 211,576$1,618,5570.00%
External links

This page lists RECURSION PHARMACEUTICALS IN's shareholders in Q3 2023. To view RECURSION PHARMACEUTICALS IN's shareholder history, click here.